city New Delhi India city Mumbai city Delhi city Pune covid-19 testing Government infection city New Delhi India city Mumbai city Delhi city Pune

Cipla approaches ICMR to make ELISA antibody test kits

Reading now: 343
www.livemint.com

New Delhi: After initially rejecting the government’s offer, Cipla has approached the Indian Council of Medical Research (ICMR) for non-exclusive licenses to produce the antibody testing kit developed by the National Institute of Virology in Pune, ICMR said on Thursday.

The Mumbai-based pharmaceutical giant and a Delhi-based firm NextGen Life Science Pvt Ltd have now approached the country’s apex biomedical research body to get non-exclusive licenses to produce the critical ELISA test kits, ICMR said.

ELISA, which is an abbreviation of enzyme-linked immunosorbent assay, is a test which measures the antibodies IgG present in the blood against the novel coronavirus SARS-CoV2.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA